Postmenopausal women with medically treated diabetes have increased risk of lung cancer by Leitzmann, Michael
Quantitative study
Postmenopausal women with medically treated diabetes
have increased risk of lung cancer
Michael Leitzmann
Commentary on: Luo J, Chlebowski R, Wactawski-Wende J, et al. Diabetes and lung cancer among
postmenopausal women. Diabetes Care 2012;35:1485–91.
Implications for practice and research
▪ Lung cancer may potentially be added to the list
of cancers directly related to diabetes or insulin
treatment.
▪ Current evidence is insufﬁcient to consider lung
cancer risk as the basis for selecting appropriate
diabetes therapy.
▪ Diabetes patients who require insulin therapy for
metabolic control should continue to be treated with
insulin.
Context
Considerable epidemiological evidence suggests that type
2 diabetes is associated with increased risk of developing
various types of malignancies, most notably cancers of
the liver, pancreas, endometrium, colorectum, breast and
bladder. In contrast, type 2 diabetes has previously not
been widely thought to be linked with lung cancer.1 The
relation of diabetes to lung cancer is complex and
the study by Luo and colleagues addresses a number of
important methodological challenges in this research area.
Methods
In a large prospective cohort study of 145 765 postme-
nopausal women from the U.S Women’s Health
Initiative, the authors examined the relationships of type
2 diabetes and diabetes therapy to lung cancer risk.
Detailed information on diabetes status and diabetes
therapy was assessed using self-reports at study baseline
and during follow-up. Women with diabetes were
grouped into four categories according to diabetes treat-
ment type: (1) no diabetes medication, (2) metformin
alone, (3) other oral medication alone and (4) insulin
(alone or in combination with oral medication). Lung
cancer incidence was also based on the participants’
self-report and was subsequently conﬁrmed by a review
of medical records and pathology reports.
Findings
During 11 years of follow-up, 2257 incident cases of
lung cancer were ascertained. The multivariable HR of
lung cancer comparing women with treated type 2 dia-
betes to those without diabetes was 1.27 (95% CI 1.02 to
1.59). The positive association between treated diabetes
and lung cancer was particularly strong among women
requiring insulin treatment (HR=1.71, 95% CI 1.15 to
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2.53). The ﬁnding of an increased lung cancer risk
among patients with diabetes, or among them treated
with insulin, is consistent with several recent studies on
this topic.2–4
Commentary
A notable strength of this study is the collection of
detailed information on potential confounding factors.
This is important because the biological mechanisms
through which diabetes affects lung cancer may operate
through shared risk factors, such as smoking or a poor
diet. A further positive asset of the study is the availabil-
ity of data on duration of diabetes as a predictor of lung
cancer risk. While no overall association was found with
diabetes duration, lung cancer risk was suggestively
greater during the ﬁrst 6 years after diabetes diagnosis
(HR=1.23, 95% CI 0.93 to 1.61) than 6 years or more after
diabetes diagnosis (HR=0.98, 95% CI 0.74 to 1.29).
It is critical to consider the possibility of detection
bias because heightened medical surveillance among
diabetics may have resulted in lung cancers being
detected more frequently or diagnosed earlier than in
non-diabetics, thereby spuriously increasing lung cancer
risk, particularly during the initial period of follow-up.
There is previous epidemiological evidence of potential
detection bias in the assessment of lung cancer risk in
diabetics, with a 170% increased risk of lung cancer
among diabetics in the initial 3-month follow-up period
following a new diagnosis of diabetes, which subse-
quently became null after the initial 3-month time
window.5
An additional methodological issue is confounding
by indication. Insulin is typically administered to
patients who have not responded to oral medication or
those who have contraindications to glucose-lowering
drugs, such as renal, hepatic or cardiovascular disease.
Thus, there is potential for confounding by indication
if failure of oral medication or the development of ill
health is linked to risk factors for lung cancer (such as
smoking) or preclinical lung cancer. A further methodo-
logical concern is the possibility of reverse causation,
which could occur if lung cancer worsens glycaemic
control prior to diagnosis, thereby necessitating a
change from oral drugs to insulin therapy.
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